ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Lattice Biologics Ltd (CE)

Lattice Biologics Ltd (CE) (LBLTF)

0.000001
0.00
( 0.00% )
Updated: 19:00:00
Advanced chart

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.000001
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.000001 52 Week Range 0.000001
Previous Close
0.000001
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
2,000
Financial Volume
-
VWAP
-

LBLTF Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12001.0E-61.0E-61.0E-620001.0E-6CS
26001.0E-61.0E-61.0E-610001.0E-6CS
52001.0E-61.0E-61.0E-632861.0E-6CS
156-0.017999-99.99444444440.0180.0181.0E-684707.561E-5CS
260-0.019999-99.9950.020.56841.0E-6435960.05362076CS

LBLTF - Frequently Asked Questions (FAQ)

What is the current Lattice Biologics (CE) share price?
The current share price of Lattice Biologics (CE) is $ 0.000001
What is the 1 year trading range for Lattice Biologics (CE) share price?
Lattice Biologics (CE) has traded in the range of $ 0.000001 to $ 0.000001 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
HTGMQHTG Molecular Diagnostics Inc (CE)
$ 0.001
(99,900.00%)
5.74k
ZHCLFZenith Capital Corporation (CE)
$ 0.10
(99,900.00%)
8.5k
NEPTFNeptune Wellness Solutions Inc (CE)
$ 0.0002
(19,900.00%)
1.53k
JFTHJapan Food Tech Holdings Inc (CE)
$ 0.0002
(19,900.00%)
17.1k
IMTLImage Protect Inc (PK)
$ 0.0001
(9,900.00%)
4.76M
LRDSFLords and Company Worldwide Holdings Inc (CE)
$ 0.000001
(-99.50%)
50k
PLPLPlandai Biotechnology Inc (PK)
$ 0.000001
(-99.00%)
500k
BRGOBergio International Inc (PK)
$ 0.000001
(-99.00%)
778k
NAFSNorth America Frac Sand Inc (PK)
$ 0.000001
(-99.00%)
10k
FTEGFor The Earth Corporation (CE)
$ 0.000001
(-99.00%)
815k
HMBLHUMBL Inc (PK)
$ 0.00045
(-10.00%)
196.19M
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.00255
(-1.92%)
163.9M
RONNRonn Motor Group Inc (PK)
$ 0.0002
(-20.00%)
98.3M
BOMObowmo Inc (PK)
$ 0.0002
(100.00%)
89.32M
OZSCOzop Energy Solutions Inc (PK)
$ 0.00024
(20.00%)
68.95M

LBLTF Discussion

View Posts
Joecanada13 Joecanada13 5 years ago
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) is pleased to announce that it has entered into a definitive agreement (the "Agreement") with Alumina Partners (Ontario) Ltd. ("Alumina") for a commitment of up to$6,000,000 CDN (six million dollars) in an at-will offering facility (the "Facility"). This facility replaces the previously announced private placement announced on March 17th, 2020.

Pursuant to the terms of the Agreement, for a period of twenty four months the Company has the right to draw down on the Facility, at any time, at its sole election, in equity private placement tranches of up to $1,000,000. Each tranche will be comprised of units ("Units") with each Unit consisting of one common share ("Share") and one common share purchase warrant ("Warrant"), at discounts between 15-25% of the closing price of the shares on the day prior to Lattice Biologics’ drawdown notice to Alumina.

The exercise price of the Warrants will be at a 25% premium over the market price at the time of issuance and have a term of three years. Further, the Warrants will also contain a provision for accelerated expiry should Lattice Biologics’ Shares trade on the TSX-V, for a period of 10 consecutive trading days, at a premium of at least 200% above the warrant exercise price.

This Facility will provide additional financial flexibility for Lattice Biologics as it accelerates its growth to support Phase 1 trials for its stem cell-based treatment of COVID-19. The expected capital allocation to secure Phase 1 approval is $1 million. The initial tranche can be up to $1,000,000 and is subject to TSX approval. Subsequent transactions are also subject to TSX approval. The minimum price for any financing under the facility is the Discounted Market Price allowable under TSXV policies at the time of the announcement which could range from 15-25%.

The terms of the Facility are structured so that funds may be drawn on an as needed basis, allowing Lattice Biologics to finance as it achieves clinical milestones. There are no transaction fees associated with the facility, no minimum amounts that must be drawn down and no penalties in the event that Lattice Biologics elects not to draw upon the facility.

Guy Cook, Lattice Biologics’ CEO, commented: "We are excited to enter into this facility with Alumina Partners which will support our Phase I trials. I am delighted that the principals of Alumina share our vision of novel stem cell-based therapeutics. The capital will help fuel our growth at a critical juncture."

“We are thrilled to invest in Lattice as they embark upon Phase I trials of AmnioBoost,” said Adi Nahmani, Managing Member of Alumina Partners. “As medical science struggles to identify safe and effective treatment candidates for COVID-19, every avenue must be explored with all due haste. AmnioBoost is ready for clinical trials, and we look forward to seeing a fully capitalized Lattice move that ball forward.”
👍️0
Joecanada13 Joecanada13 5 years ago
Nice consolidation today
👍️0
Self-Made Self-Made 5 years ago
Way under the radar.
👍️0
Joecanada13 Joecanada13 5 years ago
Big run coming here.
👍️0
retireat40 retireat40 5 years ago
Fantastic run so far. Looking for .20 tomorrow.
👍️0
Ryguy008 Ryguy008 5 years ago
Great gains so far! News today- https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/lattice-biologics-ltd-announces-initial-recruitment-of-patients-for-a-phase-1-clinical-trial-to-access-safety-and-efficacy-of-amnioboost-for-treatment-of-covid-19

Chart here- https://twitter.com/HandsTiedBull/status/1239924198165958656

$LBLTF
👍️0
Tcent Tcent 8 years ago
This is actually a nice step up for this start up. It's now on
the OTC pink sheets instead of grey listed.
👍️0
Renee Renee 8 years ago
BLVKF changed to LBLTF:

http://otce.finra.org/DLSymbolNameChanges
👍️0